In addition, we show that LPCAT2 overexpression and LD overproduction confer CRC cell chemoresistance by blocking chemotherapy-induced ER stress, calreticulin (CRT) membrane translocation and subsequent immunogenic cell death (ICD). Here, LPCAT2 is linked to colorectal carcinoma.